Transgenic mouse model for skin malignant melanoma

Oncogene

Volumn 17, Issue 14, 1998, Pages 1885-1888

  Kato, Masashi ^a   Takahashi, Masahide ^a   Akhand, Anwarul A ^a   Liu, Wei ^a   Dai, Yan ^a   Shimizu, Satoru ^b   Iwamoto, Takashi ^a   Suzuki, Haruhiko ^a   Nakashima, Izumi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Malignant melanoma; Ret; Transgenic mouse

Indexed keywords

MATRIX METALLOPROTEINASE; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE ACTIVITY; GENE EXPRESSION; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MELANOSIS; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; TRANSGENE;

EID: 0032497642     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202077     Document Type: Article

References (20)

1. Balch CM, Houghton A and Peters L. (1989). Principles and Practice of Oncology: Cancer. De Vita VT Jr, Hellman S and Rosenberg SA (eds). Lippincott: Philadelphia, pp. 1519-1542.
2. Bradl M, Klein-Szanto A, Porter S and Mintz B. (1991). Proc. Natl. Acad. Sci. USA, 88, 164-168.
3. Chen S, Zhu H, Wetzel WJ and Philbert MA. (1996). J. Invest. Dermatol., 106, 1145-1151.
4. Crawford C and Matrisian M. (1994). Invasion Metastasis, 14, 234-245.
5. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Handy A and Balkwill F. (1993). Cancer Res., 53, 5365-5369.
6. Himelstein BP, Canete-Soler R, Bernhard E, Dilks DW and Muschel R. (1994). Invasion Metastasis, 14, 246-258.
7. Iwamoto T, Takahashi M, Ito M, Hamatani K, Ohbayashi M, Wajjwalku W, Isobe K and Nakashima I. (1991). EMBO J., 10, 3167-3175.
8. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N and Okada Y. (1996). Jpn. J. Cancer Res., 87, 602-611.
9. Kato M, Pu M, Isobe K, Iwamoto T, Nagase F, Lwin T, Zhang YH, Hattori T, Yanagita N and Nakashima I. (1994). Cell. Immunol., 159, 15-25.
10. Koh HK and Bhawan J. (1992). Tumors of the skin: Dermatology. 3rd edition WB Saunders Company: Philadelphia, pp. 1753.
11. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM and DeClerck YA. (1994). Cancer Res., 54, 5467-5473.
12. Ohmiya N, Ito M, Ohbayashi M, Arisawa T, Goto H, Tsukamoto V, Hayakawa T and Asai J. (1995). Clin. Exp. Immunol., 100, 151-156.
13. Pu M, Akhand AA, Kato M, Hamaguchi M, Koike T, Iwata H, Sabe S, Suzuki H and Nakashima I. (1996). Oncogene, 13, 2615-2622.
14. Sakata K, Kozaki K, Iida K, Tanaka R, Yamagata S, Utsumi KR, Saga S, Shimizu S and Matsuyama M. (1996). Jpn. J. Cancer Res., 87, 78-85.
15. Sato H, Kita M and Seiki M. (1993). J. Biol. Chem., 268, 23460-23468.
16. Takahashi M, Asai N, Iwashita T, Isomura T, Miyazaki K and Matsuyama M. (1993). Oncogene, 8, 2925-2929.
17. Takahashi M, Ritz J and Cooper GM. (1985). Cell, 42, 581-588.
18. Taniguchi M, Iwamoto T, Nakashima I, Nakayama A, Ohbayashi M, Matsuyama M and Takahashi M. (1992). Oncogene, 7, 1491-1496.
19. Yamagata S, Ito Y, Tanaka R and Shimizu S. (1988). Biochem. Biophys. Res. Commun., 151, 158-162.
20. Yamagata S, Tanaka R, Ito Y and Shimizu S. (1989). Biochem. Biophys. Res. Commun., 158, 228-234.